Literature DB >> 25161017

Intravenous fluid use after cardiac surgery: a multicentre, prospective, observational study.

Rachael L Parke1, Shay P McGuinness2, Eileen Gilder2, Lianne W McCarthy2.   

Abstract

BACKGROUND: The optimal strategy for fluid replacement after major surgery remains unclear and there is considerable interest in the investigation of more restrictive fluid regimens.
OBJECTIVE: We aimed to establish current practice of fluid administration to patients after cardiac surgery. DESIGN, SETTING AND PARTICIPANTS: A multicentre, prospective observational study, over an 8-week period, of consecutive patients admitted to five intensive care units in New Zealand and Australia. MAIN OUTCOME MEASURES: We collected patient demographic data and details of fluid boluses and all other intravenous (IV) fluids administered in the first 24 hours after ICU admission.
RESULTS: We included 235 patients, and 1226 fluid boluses with an average volume of 504 mL/bolus were administered. The median total fluid given for volume expansion in the first 24 hours was 2250mL (interquartile range [IQR], 1250-3500mL) from a median total IV fluid intake of 4493mL/patient (IQR, 2842-5498 mL). The decision to administer a fluid bolus was made 40% of the time by nursing staff, 45% by an ICU resident and 12% by an ICU specialist. The most common reason for fluid administration was hypotension (65%), and crystalloid fluid was used for 65% of the boluses.
CONCLUSIONS: We showed that fluid boluses are responsible for a large proportion of the positive fluid balance seen in patients after cardiac surgery. These data justify further study to evaluate whether modification of fluid bolus administration can improve patient outcomes.

Entities:  

Mesh:

Year:  2014        PMID: 25161017

Source DB:  PubMed          Journal:  Crit Care Resusc        ISSN: 1441-2772            Impact factor:   2.159


  5 in total

1.  A randomized feasibility study to assess a novel strategy to rationalize fluid in patients after cardiac surgery.

Authors:  R L Parke
Journal:  Br J Anaesth       Date:  2016-07       Impact factor: 9.166

2.  Albumin Use After Cardiac Surgery.

Authors:  Mbakise P Matebele; Mahesh Ramanan; Kelly Thompson; George Cornmell; Rishendran V Naidoo; Kiran Shekar
Journal:  Crit Care Explor       Date:  2020-07-15

3.  STS/SCA/AmSECT/SABM Update to the Clinical Practice Guidelines on Patient Blood Management.

Authors:  Pierre Tibi; R Scott McClure; Jiapeng Huang; Robert A Baker; David Fitzgerald; C David Mazer; Marc Stone; Danny Chu; Alfred H Stammers; Tim Dickinson; Linda Shore-Lesserson; Victor Ferraris; Scott Firestone; Kalie Kissoon; Susan Moffatt-Bruce
Journal:  J Extra Corpor Technol       Date:  2021-06

Review 4.  Albumin in adult cardiac surgery: a narrative review.

Authors:  Ciara Hanley; Jeannie Callum; Keyvan Karkouti; Justyna Bartoszko
Journal:  Can J Anaesth       Date:  2021-04-21       Impact factor: 6.713

5.  Fluid bolus therapy is a medical therapy or a diagnostic method?

Authors:  Huaiwu He; Dawei Liu
Journal:  Crit Care       Date:  2015-10-13       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.